Novagali’s Product Portfolio
Fully integrated product development: from research to market authorization
Our pipeline includes products at various stage of development that address diseases of the three segments of the eye.

Our pipeline includes products at various stage of development that address diseases of the three segments of the eye.
| Products | Pre - clinical | Phase 1 | Phase 2 | Phase 3 | Registration | Marketing | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Surface |
Cationorm® MILD DRY EYE |
X | X | X | X | X | X | X | X | X | X | X | X | ||
| Vekacia® Cyclosporine A VKC |
X | X | X | X | X | X | X | ||||||||
| Cyclokat® Cyclosporine A MODERATE TO SEVERE DRY EYE |
X | X | X | X | X | X | X | ||||||||
| Anterior Segment |
Catioprost® Latanoprost GLAUCOMA |
X | X | X | X | X | |||||||||
| Posterior Segment |
Cortiject® Corticosteroid DIABETIC MACULAR EDEMA |
X | X | X | |||||||||||